Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Diagnostics is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD,
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
Sevo Neutraceuticals, a portfolio company of Fayetteville's VIC Technology Venture Development, announces a patent for its Perceptiv product, a supplement for brain health and cognitive performance.
EAST students at Greenbrier High School are among those who stand to benefit from a DRA grant that will speed the opening of the Launch Pad maker space in the Argenta Innovation Center.
The nonprofit Arkansas Regional Innovation Hub announces a $250,000 grant from the Delta Regional Authority to be used for program support and administrative operations at the planned Argenta Innovation Center.
October was a good month for two Little Rock startup tech firms, Treatsie LLC and Bourbon & Boots Inc. of Little Rock, which received a total of $650,000 in investments.